Aller au contenu
Retour au classement

GEO Benchmark

techtransfer.nih.gov

governmentUSEN11 pages
79/ 100

Signaux de citabilité

Forces

Sources et citations
76
Naturalité
76

À renforcer

Structure du contenu
36

Autorité réelle des sources

Le classement d'autorité de chaque source citée (au-delà du regex) et le plan d'action détaillé, dans DataGeo.

Voir sur DataGeo
Pages analysées (11)
  1. 01
    A Low-Cost Tissue Microarrayer Instrument to Support Improved Cancer Diagnoses
    other435 mots/kudo/a-low-cost-tissue-microarrayer-instrument-to-support-improved-cancer-diagnoses
    89.8
  2. 02
    Development of First Immunotherapy to Treat Chordoma
    other403 mots/kudo/development-of-first-immunotherapy-to-treat-chordoma
    85.9
  3. 03
    Development of First Immunotherapy to Treat Chordoma, a Rare Bone Cancer
    other406 mots/kudo/development-of-first-immunotherapy-to-treat-chordoma-a-rare-bone-cancer
    85.9
  4. 04
    Interleukin-2 Receptor Gamma Deficient Mice, Widely Used Research Tools
    other469 mots/kudo/interleukin-2-receptor-gamma-deficient-mice-widely-used-research-tools
    85.8
  5. 05
    Novel Therapeutics to Treat Niemann-Pick C Disease and Other Lysosomal Disorders
    other473 mots/kudo/novel-therapeutics-to-treat-niemann-pick-c-disease-and-other-lysosomal-disorders
    81.7
  6. 06
    Deep Transcranial Magnetic Stimulation Coil and Therapy System
    other467 mots/kudo/deep-transcranial-magnetic-stimulation-coil-and-therapy-system
    76.9
  7. 07
    NIH International Technology Transfer Mentoring Program
    other540 mots/kudo/nih-international-technology-transfer-mentoring-program
    74.8
  8. 08
    Discovery to Market
    other430 mots/kudo/discovery-to-market
    74.3
  9. 09
    Discovery to Commercialization: New Immunotherapy for Rare Childhood Cancer, Neuroblastoma
    other404 mots/kudo/discovery-to-commercialization-new-immunotherapy-for-rare-childhood-cancer-neuroblastoma
    73.6
  10. 10
    First FDA Approval: Combination Therapy for Rare Childhood Cancer, Neuroblastoma
    other404 mots/kudo/first-fda-approval-combination-therapy-for-rare-childhood-cancer-neuroblastoma
    73.6

Excellent : bien optimisé pour la recherche IA

Le contenu de ce site est bien structure, ecrit par des humains et appuye par des sources credibles. Les moteurs IA sont susceptibles de le citer.

Intégrer ce badge sur votre site

GEO Score badge for techtransfer.nih.gov
<a href="https://datageo.fr/benchmark-geo/techtransfer.nih.gov" target="_blank" rel="noopener">
  <img src="https://api.datageo.ai/api/v1/benchmark/badge/techtransfer.nih.gov.svg" alt="GEO Score for techtransfer.nih.gov" width="180" height="40" />
</a>
Visiter techtransfer.nih.gov

Dernière analyse: 6/30/2026

Améliorer ce score ?

Obtenez une analyse IA détaillée avec des recommandations et une optimisation automatique du contenu.

techtransfer.nih.gov · GEO Score: 79/100 | DataGEO Benchmark | DataGEO